OBJECTIVES: We sought to determine the gender-specific effects of obesity on myocardial metabolism, work, and efficiency. BACKGROUND: Myocardial metabolism abnormalities may contribute to the development of obesity-related heart failure. Increased myocardial oxygen consumption (MVO(2)) and fatty acid (FA) metabolism and decreased efficiency occur with obesity in women. It is unknown whether similar changes occur with obesity in men. METHODS: We quantified cardiac work, efficiency, myocardial blood flow (MBF), MVO(2), glucose, and FA metabolism with echocardiography and positron emission tomography in nonobese and obese men and women (N = 86). RESULTS: There were significant differences between the obese (n = 35) and nonobese (n = 51) subjects in age, body composition, plasma lipids, and insulin resistance in addition to differences between the men (n = 30) and women (n = 56) in body composition and plasma lipids. Female gender independently predicted increased cardiac work (p < 0.001). Female gender also related to lower efficiency (p < 0.05). Obesity and female gender independently predicted greater MBF (p < 0.01, p < 0.0005, respectively) and MVO(2) (p < 0.0005, p < 0.0001). Myocardial glucose uptake was not different among the 4 subject groups, but obesity and gender interacted in predicting glucose uptake (p < 0.05). Lower myocardial glucose utilization was independently predicted by female gender (p < 0.05), and it independently predicted lower myocardial glucose utilization/plasma insulin (p < 0.05). Obesity and gender significantly interacted in the determination of glucose utilization/plasma insulin (p = 0.01). There were no differences in FA uptake among the 4 groups, and although increasing obesity correlated with greater myocardial FA utilization and oxidation; female gender (p < 0.005, p < 0.01) and plasma triglycerides (p < 0.05, p < 0.005) were their independent predictors. CONCLUSIONS: Women's and men's myocardial metabolic responses to obesity are not exactly the same. Obesity and gender modulate MBF and MVO(2), are related to myocardial substrate metabolism, and sometimes interact in its prediction. Gender modifies efficiency. Gender-related differences in myocardial metabolism may affect the development of/adaptation to obesity-related cardiac disease.
OBJECTIVES: We sought to determine the gender-specific effects of obesity on myocardial metabolism, work, and efficiency. BACKGROUND:Myocardial metabolism abnormalities may contribute to the development of obesity-related heart failure. Increased myocardial oxygen consumption (MVO(2)) and fatty acid (FA) metabolism and decreased efficiency occur with obesity in women. It is unknown whether similar changes occur with obesity in men. METHODS: We quantified cardiac work, efficiency, myocardial blood flow (MBF), MVO(2), glucose, and FA metabolism with echocardiography and positron emission tomography in nonobese and obesemen and women (N = 86). RESULTS: There were significant differences between the obese (n = 35) and nonobese (n = 51) subjects in age, body composition, plasma lipids, and insulin resistance in addition to differences between the men (n = 30) and women (n = 56) in body composition and plasma lipids. Female gender independently predicted increased cardiac work (p < 0.001). Female gender also related to lower efficiency (p < 0.05). Obesity and female gender independently predicted greater MBF (p < 0.01, p < 0.0005, respectively) and MVO(2) (p < 0.0005, p < 0.0001). Myocardial glucose uptake was not different among the 4 subject groups, but obesity and gender interacted in predicting glucose uptake (p < 0.05). Lower myocardial glucose utilization was independently predicted by female gender (p < 0.05), and it independently predicted lower myocardial glucose utilization/plasma insulin (p < 0.05). Obesity and gender significantly interacted in the determination of glucose utilization/plasma insulin (p = 0.01). There were no differences in FA uptake among the 4 groups, and although increasing obesity correlated with greater myocardial FA utilization and oxidation; female gender (p < 0.005, p < 0.01) and plasma triglycerides (p < 0.05, p < 0.005) were their independent predictors. CONCLUSIONS:Women's and men's myocardial metabolic responses to obesity are not exactly the same. Obesity and gender modulate MBF and MVO(2), are related to myocardial substrate metabolism, and sometimes interact in its prediction. Gender modifies efficiency. Gender-related differences in myocardial metabolism may affect the development of/adaptation to obesity-related cardiac disease.
Authors: Linda R Peterson; Pablo F Soto; Pilar Herrero; Kenneth B Schechtman; Carmen Dence; Robert J Gropler Journal: J Nucl Cardiol Date: 2007-06-27 Impact factor: 5.952
Authors: Y T Zhou; P Grayburn; A Karim; M Shimabukuro; M Higa; D Baetens; L Orci; R H Unger Journal: Proc Natl Acad Sci U S A Date: 2000-02-15 Impact factor: 11.205
Authors: Biao Lei; Ken Matsuo; Volodymyr Labinskyy; Naveen Sharma; Margaret P Chandler; Anna Ahn; Thomas H Hintze; William C Stanley; Fabio A Recchia Journal: Proc Natl Acad Sci U S A Date: 2005-05-03 Impact factor: 11.205
Authors: Tarja A Kunnas; Terho Lehtimäki; Pekka J Karhunen; Reijo Laaksonen; Tuula Janatuinen; Risto Vesalainen; Pirjo Nuutila; Juhani Knuuti; Seppo T Nikkari Journal: J Mol Med (Berl) Date: 2004-10-27 Impact factor: 4.599
Authors: Andrew M Kates; Pilar Herrero; Carmen Dence; Pablo Soto; Muthayyah Srinivasan; Deborah G Delano; Ali Ehsani; Robert J Gropler Journal: J Am Coll Cardiol Date: 2003-01-15 Impact factor: 24.094
Authors: Janet B McGill; Linda R Peterson; Pilar Herrero; Ibrahim M Saeed; Carol Recklein; Andrew R Coggan; Amanda J Demoss; Kenneth B Schechtman; Carmen S Dence; Robert J Gropler Journal: J Nucl Cardiol Date: 2011-04-23 Impact factor: 5.952
Authors: Linda R Peterson; Ibrahim M Saeed; Janet B McGill; Pilar Herrero; Kenneth B Schechtman; Ratnasiri Gunawardena; Carol L Recklein; Andrew R Coggan; Amanda J DeMoss; Carmen S Dence; Robert J Gropler Journal: Obesity (Silver Spring) Date: 2011-08-04 Impact factor: 5.002
Authors: C Huie Lin; Suraj Kurup; Pilar Herrero; Kenneth B Schechtman; J Christopher Eagon; Samuel Klein; Víctor G Dávila-Román; Richard I Stein; Gerald W Dorn; Robert J Gropler; Alan D Waggoner; Linda R Peterson Journal: Obesity (Silver Spring) Date: 2011-07-07 Impact factor: 5.002
Authors: Heinrich Taegtmeyer; Martin E Young; Gary D Lopaschuk; E Dale Abel; Henri Brunengraber; Victor Darley-Usmar; Christine Des Rosiers; Robert Gerszten; Jan F Glatz; Julian L Griffin; Robert J Gropler; Hermann-Georg Holzhuetter; Jorge R Kizer; E Douglas Lewandowski; Craig R Malloy; Stefan Neubauer; Linda R Peterson; Michael A Portman; Fabio A Recchia; Jennifer E Van Eyk; Thomas J Wang Journal: Circ Res Date: 2016-03-24 Impact factor: 17.367
Authors: Matthew R Lyons; Linda R Peterson; Janet B McGill; Pilar Herrero; Andrew R Coggan; Ibrahim M Saeed; Carol Recklein; Kenneth B Schechtman; Robert J Gropler Journal: Am J Physiol Heart Circ Physiol Date: 2013-09-16 Impact factor: 4.733
Authors: Daisuke Kamimura; Takeki Suzuki; Wanmei Wang; Matthew deShazo; John E Hall; Michael D Winniford; Iftikhar J Kullo; Thomas H Mosley; Kenneth R Butler; Michael E Hall Journal: Hypertens Res Date: 2018-06-15 Impact factor: 3.872